TheBullseye

Moderna $MRNA

做多
NASDAQ:MRNA   Moderna, Inc.
Moderna is one of the best pick for COVID-19 vaccine. They have already started dosing patients and expect the vaccine to be available for high-risk people like healthcare workers in the Fall this year.
The strength is rising and needs to close above $36 by the end of next week.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。